DANISH Score (ICD Benefit Model) Calculator

Clinical calculation support · Verify results before clinical use

Clinical context assessment

Review selected characteristics alongside evidence from the DANISH trial.

Evidence context · Not a validated score

Enter the patient characteristics below to display trial-context reminders. This tool does not calculate an individual probability of benefit and must not replace guideline-based ICD assessment or shared decision-making.

Age subgroup findings are contextual evidence, not a stand-alone indication or contraindication.
Enter the most recent clinically appropriate LVEF measurement.
The DANISH trial eligibility criteria included NT-proBNP >200 pg/mL.

Clinical background

The DANISH trial evaluated prophylactic implantable cardioverter-defibrillator (ICD) implantation in patients with non-ischemic systolic heart failure. The original trial did not show a statistically significant reduction in all-cause mortality in the overall study population, although sudden cardiac death was reduced.

A prespecified age analysis suggested that the association between ICD implantation and all-cause mortality differed by age. Extended follow-up reported an association with lower all-cause mortality in patients aged 70 years or younger, but not in those older than 70 years. These subgroup findings should be interpreted in context and do not establish a universal age cutoff for individual decisions.

Selected trial characteristics

CharacteristicDANISH trial context
EtiologyNon-ischemic systolic heart failure
LVEF≤35%
SymptomsNYHA II–III; NYHA IV when CRT was planned
NT-proBNP>200 pg/mL

These are selected trial characteristics, not a complete contemporary ICD guideline checklist. Clinical eligibility depends on the full evidence base, current guidelines, optimized medical therapy, competing risks, life expectancy, and patient preferences.

References

Køber L, Thune JJ, Nielsen JC, et al.

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med. 2016;375:1221–1230.

doi:10.1056/NEJMoa1608029
Elming MB, Nielsen JC, Haarbo J, et al.

Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.

PubMed: 28877914
Yafasova A, Butt JH, Elming H, et al.

Long-Term Follow-Up of DANISH. Circulation. 2022;145:427–436.

PubMed: 34882430
Clinical disclaimer: This tool is intended for educational support only. It does not calculate a validated “DANISH Score,” predict a patient's absolute or relative ICD benefit, or determine whether an ICD should be implanted. Base clinical decisions on current guidelines, the full clinical profile, shared decision-making, and specialist assessment.